...
首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6
【24h】

A single nucleotide variant in microRNA-1269a promotes the occurrence and process of hepatocellular carcinoma by targeting to oncogenes SPATS2L and LRP6

机译:MicroRNA-1269A中的单个核苷酸变体促进肝细胞癌的发生和过程,靶向鞘膜蛋白酶SPATS2L和LRP6

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Hepatocellular carcinoma (HCC) is one of the malignant and lethal cancers. Single nucleotide polymorphisms (SNPs) in microRNAs(miRNAs) can affect the expression and target identification of miRNAs and lead to the formation of malignant tumors. However, little is known about whether microRNA-1269a (miR-1269a) SNPs affect the susceptibility and progression of HCC or their specific mechanism. The association between microRNA-1269a rs73239138 and the susceptibility to HCC was verified by MassARRAY assay in a large case-control sample. The effect of miR-1269a and the variant on the proliferation and apoptosis of HCC cells was examined by flow cytometry (FCM), CCK8 assay and Western blot. The target of miR-1269a was identified by bioinformatics analysis and qRT-PCR and its role on cell proliferative capacity was examined by CCK8 assay. The expression level of miR-1269a was analyzed by qRT-PCR in HCC cells transfected with wild or variant type pre-miR-1269a plasmid.MiR-1269a produced a tumor suppressor effect by inhibiting cell proliferation and inducing apoptosis of human HCC cells, possibly via inhibiting the expression of its target genes SPATS2L and LRP6 , which were tumor promoters. While, rs73239138 (G A) in miR-1269a reduced the anticancer effect of miR-1269a possibly by attenuating its total amount in HCC cells or its target recognition, reduce its inhibition on target genes and promoted the susceptibility to HCC. Our findings for the first time proved that miR-1269a SNP plays a role in the occurrence and process of HCC and the relevant mechanism, in accompany with the discovery of the novel target genes of miR-1269a .
机译:发明内容肝细胞癌(HCC)是恶性和致死的癌症之一。 MicroRNA中的单核苷酸多态性(SNP)(miRNA)可以影响miRNA的表达和靶标识,导致形成恶性肿瘤。然而,关于microRNA-1269A(miR-1269A)SNP是否影响HCC或其特定机制的敏感性和进展几乎是知之甚少。 MicroRNA-1269A RS73239138之间的关联和对HCC的敏感性通过MassArray测定在大壳体对照样品中验证。通过流式细胞术(FCM),CCK8测定和Western印迹检查miR-1269a和变体对HCC细胞增殖和凋亡的影响。通过生物信息化学分析鉴定miR-1269a的靶标,并通过CCK8测定检测QRT-PCR及其对细胞增殖能力的作用。通过用野生或变体型预热剂预热的HCC细胞中的QRT-PCR分析miR-1269a的表达水平.mir-1269a,通过抑制细胞增殖并诱导人HCC细胞凋亡,产生肿瘤抑制效果。可能通过抑制其靶基因SPATS2L和LRP6的表达,即肿瘤启动子。虽然MiR-1269A中的RS73239138(g> a)减少了MiR-1269a的抗癌效果,可能通过衰减其HCC细胞中的总量或其目标识别,降低其对靶基因的抑制并促进对HCC的敏感性。我们第一次首次证明MIR-1269A SNP在HCC的发生和过程中发挥作用和相关机制,伴随着发现MIR-1269A的新靶基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号